The American company Novavax announced the beginning of clinical trials of a new vaccine against coronavirus in humans. The trial grant was awarded by an agency founded by billionaire and philanthropist Bill Gates. Writes about this RT with reference to the official statement of the company. The experiment will involve about 130 adult volunteers from Australia. During the first phase of the trial, they will receive two doses of an experimental vaccine called NVX-CoV2373. In case the first results, which are expected in July, prove promising, the company plans to immediately move to the second phase. It is assumed that in the second stage, other countries and different age groups will participate in the experiment.
“The introduction of our vaccine to the early participants in this clinical trial is a significant advance that takes us one step closer to meeting the fundamental need for a vaccine in the fight against the global COVID-19 pandemic,” said Stanley Erck, President and CEO of Novavax. The vaccine development began with a $ 388 million investment from the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI), a public health foundation created by Microsoft founder Bill Gates.
Bill Gates sponsored human trial of coronavirus vaccine
The American company Novavax announced the beginning of clinical trials of a new vaccine against coronavirus in humans. The trial grant was awarded by an agency founded by billionaire and philanthropist Bill Gates. Writes about this RT with reference to the official statement of the company. The experiment will involve about 130 adult volunteers from Australia. During the first phase of the trial, they will receive two doses of an experimental vaccine called NVX-CoV2373. In case the first results, which are expected in July, prove promising, the company plans to immediately move to the second phase. It is assumed that in the second stage, other countries and different age groups will participate in the experiment.
“The introduction of our vaccine to the early participants in this clinical trial is a significant advance that takes us one step closer to meeting the fundamental need for a vaccine in the fight against the global COVID-19 pandemic,” said Stanley Erck, President and CEO of Novavax. The vaccine development began with a $ 388 million investment from the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI), a public health foundation created by Microsoft founder Bill Gates.
The billionaire has previously donated to a number of similar health initiatives, most notably through the Bill & Melinda Gates Foundation. This involvement of Gates in healthcare has raised a lot of suspicion and doubt among the proponents of conspiracy theories, who claim that the billionaire is a supporter of the program of "depopulation" of the Earth. In their opinion, the program will help rid the world of useless consumers. The company's announcement has caused alarm among a number of social media users. Many were quick to warn that the project was “not to be trusted,” and urged Gates himself to volunteer to become the first guinea pig and inject himself with the vaccine.
Promotional video:
The American company was not the first US biotechnology firm to launch human clinical trials in search of an effective coronavirus vaccine. Thus, the Massachusetts company Moderna began testing the vaccine in March and reported positive results. At least five other vaccines are in development elsewhere, including in China, the UK and Russia.